Refine by MP, party, committee, province, or result type.
Canada-China Relations committee I'm not an employee of those organizations, so I couldn't speak to them.
April 29th, 2024Committee meeting
Matthew Gilmour
Canada-China Relations committee It's very conceivable that this would have been a red flag. I certainly remember at the time that the nature of the concerns over the individuals, as you stated, evolved to something completely different. At the time, the level of concern was much lower—potentially even things that we could manage within the lab.
April 29th, 2024Committee meeting
Matthew Gilmour
Canada-China Relations committee Mr. Chair, in my memory it was a discussion with the senior executives within the Public Health Agency of Canada on how to initiate what was ultimately the administrative investigation. It was the orchestration of how to actually introduce this to the employees' supervisors and then to the employees themselves on the 5th of July.
April 29th, 2024Committee meeting
Matthew Gilmour
Canada-China Relations committee It's not something I've done a review of.
April 29th, 2024Committee meeting
Matthew Gilmour
Canada-China Relations committee Mr. Chair, can I hear the question again, please?
April 29th, 2024Committee meeting
Matthew Gilmour
Canada-China Relations committee Mr. Chair, the red flags would have been the ones that amounted to the discussion with CSIS in August 2018. Some of those warning signs were the affiliation with Chinese institutes. There was frequent travel to China. There were the issues that were uncovered relating to visiting scientists who were not always supervised.
April 29th, 2024Committee meeting
Matthew Gilmour
Canada-China Relations committee Mr. Chair, that's another good question. This has been part of my own reflection—even this last week, after reading all of the documents. I'm not sure if I mentioned it before, but to my knowledge, the April 2020 and June 2020 CSIS reports are not things I had seen before. That I hadn't seen them before can be explained by how I had already resigned from the position by that point, so I wouldn't have expected the employer to show them to me.
April 29th, 2024Committee meeting
Matthew Gilmour
Canada-China Relations committee Mr. Chair, I'm not sure I'm in a position to speak to that because I don't have a role within the Government of Canada anymore. I certainly do hope.... Again, judging by the conversations with the witnesses who preceded me, it sounds like the level of interaction and engagement between the leadership team at the NML and the security authorities is greatly heightened.
April 29th, 2024Committee meeting
Matthew Gilmour
Canada-China Relations committee Mr. Chair, my takeaway is that the conversations between security and the specialized scientific institutes need to be very active and profound. This can't be something that's just left as a background conversation. Again, it's one of the reasons I was pleased to hear that it sounds like this is happening now between the security agencies and the management team at the Public Health Agency of Canada and the NML.
April 29th, 2024Committee meeting
Matthew Gilmour
Canada-China Relations committee Mr. Chair, I can absolutely see how, in the light of 2024, there would be concerns over the transfer. Certainly at the time, though, we were acting upon the information we had and acting under a different operational tempo where the concern, as I stated before, was assurance on things like biosafety.
April 29th, 2024Committee meeting
Matthew Gilmour
Canada-China Relations committee Mr. Chair, it would be difficult for me to say whether it was highly unusual. Certainly the transfer of materials between different laboratories would happen on a regular basis.
April 29th, 2024Committee meeting
Matthew Gilmour
Canada-China Relations committee Mr. Chair, I think that's best coming from the current employees of the NML. I don't specifically recall. It would have been a very low incidence, if at all.
April 29th, 2024Committee meeting
Matthew Gilmour
April 29th, 2024Committee meeting
Matthew Gilmour
Canada-China Relations committee Mr. Chair, it's a very good and very valid question. I remember the nature of my concern. That email was a follow-up to my original email that had been sent to the team, where I explicitly said that I had a concern, and I outlined the nature of my concern. All the concerns were about the validity of the recipient.
April 29th, 2024Committee meeting
Matthew Gilmour
Canada-China Relations committee Mr. Chair, that's a good question. One of the examples that I haven't yet mentioned—again, drawing upon some of the practices within the U.K.—is that there's a program there called the academic technology approval scheme. This is integrated right at the national level. It's integrated with the visa scheme.
April 29th, 2024Committee meeting
Matthew Gilmour